Disparities in Cancer Care

Although 83% of Black patients with metastatic breast cancer expressed interest in clinical trials, only 40% reported having a conversation about enrollment with their health care provider, highlighting one of many potential barriers to achieving clinical trial diversity.

Strategies to combat ethnic disparities in colorectal cancer screening are not limited to the clinic.

Fixing the problem will involve holding medical institutions accountable for addressing implicit bias among providers.

The program is designed to reduce the age-adjusted death rate associated with cancer by at least 50% over the next 25 years.

An expert from the University of California Los Angeles (UCLA) discusses the alarming rate of high-risk uterine cancers among Black women and how researchers are investigating the underlying risk factors at play.

The COVID-19 pandemic has demonstrated that personalized medicine should consider social determinants of health disparities as well as genomic factors.

“We’ve had periods of time where things were shut down. We do have telemedicine, that was expanded, but telemedicine doesn’t work for everyone. If you don’t have internet access, if you don’t have the ability to understand the technology….”

While disparities exist in screening accessibility among the Hispanic/Latinx communities, the implementation of interventions have shown promising results in increased clinical trial participation.

“[Drug adherence] seems like a problem we could potentially solve or, at least, make much better, and we are not really doing enough right now to do that.”

After hearing about the difficulties a transgender man faced in receiving a cancer diagnosis, Kelly S. Haviland, PhD, FNP-BC, found her calling.

Black and Hispanic patients with cancer, as well as people with blood cancers, showed higher rates of COVID-19 diagnoses than the general cancer population.

Understanding the implications of age and gender upon safety and efficacy outcomes in patients with renal cell carcinoma is critical to the delivery of individualized care.

Retrospective results showed that African-American women with endometrial cancer are less likely to receive evidence-based care compared with white women.

There are socioeconomic and ethnic disparities in young adults who receive a diagnosis of colorectal and gastric cancers, according to Amir Khan, MD, from City of Hope.

After the widespread use of targeted therapies for breast cancer treatment, there was a wider gap in mortality rates between black and white women with the disease.

Many younger patients see more than one doctor and face misdiagnoses before being given a diagnosis of colorectal cancer (CRC), according to recent research presented during a webcast ahead of the 2019 AACR Annual Meeting.

Nurse navigators at Sarah Cannon use oncology pathways to help ensure patient access to seamless care across the cancer continuum.

Colorectal cancer mortality rates have been on the decline in California for both men and women since the mid-1990s, but for one group—Hispanic men—rates have remained essentially unchanged, and a new study suggests that lower rates of screening may be the chief driver of this disparity.

Kelly Kenzik, MS, PhD, epidemiologist at the University of Alabama at Birmingham School of Medicine, discusses her findings regarding long-term mortality disparities among African American and white women with breast cancer.

Rates of endometrial cancer continue to increase among all racial and ethnic groups, but they're rising faster among non-Hispanic black women who also have poorer outcomes when compared with their white, non-Hispanic counterparts.

Very few (1.3%) clinical cancer studies focus on people of non-white races.

Over 69% of the world's opioids is used by only 4 countries.